Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug-gene Interaction Network
Umetsu R., Tanaka M., Nakayama Y., Kato Y., Ueda N., Nishibata Y., Hasegawa S., Matsumoto K., Takeyama N., Iguchi K., Tanaka H., Hinoi E., Inagaki N., Inden M., Muto Y., and Nakamura M.
Front. Pharmacol. 12:764279. 2021.
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K., Kadota T., Horie T., Tokumura K., Terada R., Kitaguchi Y., Park G., Ochiai S., Iwahashi S., Okayama Y., Hiraiwa M., Yamada T., Iezaki T., Kaneda K., Yamamoto M., Kitao T., Shirahase H., Hazawa M., Wong RW., Todo T., Hirao A., and Hinoi E#.
Oncogene 40(15):2803-2815. 2021.
プレスリリース 岐阜大学HPに掲載 日本の研究.comに掲載 毎日新聞、日経バイオテクなどに掲載 STEMCELL TechnologiesのScience Newsに掲載
Daily oral supplementation of Hochu-Ekki-To prevents osteoclastic activation and bone loss in ovariectomized mice.
Ochiai S., Tokumura K., Park G., Ozaki K., Horie T., Yamada T., Iwahashi S., Ohta K., Fusawa H., Okayama Y., Kaneda K., Iezaki T., and Hinoi E#.
J. Pharmacol. Sci. 145(1):1-5. 2021.